WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (Kane) announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm Eastern...
WINNIPEG, Manitoba, April 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (Kane) announces that, it has completed the sale of its interest in STEM Animal Health Inc. to...
WINNIPEG, Manitoba, April 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the Company or Kane Biotech) announces today that it has reached an agreement in principle for...
Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results
WINNIPEG, Manitoba, March 20, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the Company or Kane Biotech), announces today that it has extended the exclusivity period on...
WINNIPEG, Manitoba, March 19, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the Company or Kane Biotech), a biotechnology company engaged in the research, development and...
Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award
WINNIPEG, Manitoba, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the œCompany or œKane Biotech or œKane) announces that at the special meeting of the shareholders...
WINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the œCompany or œKane Biotech or œKane) announces that it has filed a patent on its revyve„¢...
WINNIPEG, Manitoba, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the œCompany or œKane Biotech or œKane) today announces that the Company will be presenting its...